Fig. 4.
Fig. 4. Western blot analysis of TM and TF in leukemic cell lines treated with 1,25(OH)2D3. Cell lysates were subjected to immunoblotting analysis using a monoclonal anti-TM antibody (A), and a monoclonal anti-TF antibody (B). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed under nonreducing conditions. All cell lines were incubated either with (+) or without (−) 0.1 μmol/L 1,25(OH)2D3for 24 hours. Molecular-weight markers are shown along the left margin. Soluble recombinant TM (A, lane 5) and placenta TF (B, lane 3) were used as controls.

Western blot analysis of TM and TF in leukemic cell lines treated with 1,25(OH)2D3. Cell lysates were subjected to immunoblotting analysis using a monoclonal anti-TM antibody (A), and a monoclonal anti-TF antibody (B). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed under nonreducing conditions. All cell lines were incubated either with (+) or without (−) 0.1 μmol/L 1,25(OH)2D3for 24 hours. Molecular-weight markers are shown along the left margin. Soluble recombinant TM (A, lane 5) and placenta TF (B, lane 3) were used as controls.

Close Modal

or Create an Account

Close Modal
Close Modal